0
There is an ongoing debate on renaming GG1 prostate cancer due to diagnostic concerns.
1 in 6 men with GG1 may have higher-risk disease.
Study used population-based data for reliable findings.
Key distinctions between biopsy results and surgical pathology need emphasis.
Combining histopathology, imaging, and clinical features is important for risk stratification.
